NVIC Vaccine News

Impending Changes to Vaccine Injury Compensation

By Theresa Wrangham
Published April 25, 2024 in Government


March’s Advisory Commission on Childhood Vaccines (ACCV) meeting revealed that the review of medical literature requested by the U.S. Department of Health and Human Services (DHHS) from the National Academy of Medicine (NAM) is expected to be published by the end of April and was subsequently published on the National Academy of Medicine’s project webpage on April 16, 2024.1

As previously reported, the review is being conducted under the guidance of the National Childhood Vaccine Injury Act of 1986 (1986 Act)2 to determine if COVID-19 vaccines cause injuries. The ACCV will consider the report’s findings and may recommend changing the federal Vaccine Injury Table (VIT) to the Secretary of Health. The VIT is used in the federal Vaccine Injury Compensation Program (VICP) created by the 1986 Act.3 As noted in my December 2022 article, the report findings are likely to bring COVID-19 vaccine manufacturers closer to achieving the liability-free status conferred by the VICP.4 Regardless of any ACCV recommendation, the Secretary may modify the VIT through administrative rule-making and is not bound by ACCV recommendations.

Acting chair CDR Grimes M.D. advised that an ad hoc meeting before three ACCV members rotate off the commission was likely. Such a meeting would ensure there is a quorum of commissioners to consider NAM report findings and possibly making recommendations. NAM-2024-C19-SIRVA.png

Chronic Membership Vacancies

In recent years, the commission has struggled with vacancies. The commission’s charter requires nine members. There are currently three vacancies and another three of the six filled positions will rotate off the commission in August, and there is an open call for nominations to fill vacancies.5

Adult Vaccine Injury Claims and Compensation Outpaces Those of Children

The Division of Injury Compensation Programs (DICP) reported to the ACCV that for the past ten fiscal years, adult vaccine injury claims filed with the VICP had increased from 474 claims to plateau at about 1,100 for the past several years, except for the 2021 spike of nearly 2,000 claims.6

This spike in 2021 adult claims was attributed to Shoulder Injury Related to Vaccine Administration (SIRVA). Additionally, overall claim increases during the past ten years were attributed to a combination of SIRVA and flu shot injury claims. Notably, vaccine injury claims for children have remained very flat for the same period at about 150 claims per year.7

The Department of Justice’s (DOJ) report to the ACCV covered their fiscal year to date (Aug. 16, 2023, to Feb. 15, 2024) and noted that 546 vaccine injury claims were decided. Of those decided claims, 194 were concessions, 252 underwent the adversarial litigative risk process, and 100 claims were dismissed without compensation.

Vaccine Injury Compensation Trust Fund and Adequacy of Compensation

Commissioner Boyle stated his concern about award adequacy and noted that while in recent years the number of claims compensated annually by the VICP has increased, total trust fund outlays do not appear to have kept pace.8 Federal officials responded by stating such a comparison was not an indicator of award adequacy. The issue of award adequacy has been raised previously and a 2009 report commissioned by DHHS recommended DHHS get routine feedback from the vaccine injured who receive VICP compensation to help inform if awards are adequate;9 however, it is unclear if any such feedback program or evaluation of compensation adequacy has implemented.

The Vaccine Injury Trust Fund’s current balance was reported to be over $4.5 billion,10 with compensation to the vaccine injured since the program’s inception in 1989 at about $4.6 billion and their attorney’s fees at about $313 million.11

In recent years, federal officials have been scrutinizing attorney fees during ACCV meetings, and they are published monthly in the program’s monthly report.12 However, what is not provided in the monthly report are federal costs associated with processing the claims and defending the government against vaccine injury claims. That total outlay is reported to be about $273 million.13

To learn more about ACCV, meeting dates, and view NVIC’s public comments to this committee click here.



1 National Academies of Medicine. Evidence Review of the Adverse Effects of COVID-19 Vaccination and Intramuscular Vaccine Administration. Accessed Apr. 16, 2024.

2 42 U.S.C. §§ 300aa-1: Establishment. U.S. House of Representatives OLRC, Accessed Mar. 9, 2024.

3 42 U.S.C. §§ 300aa-14: Vaccine Injury Table. U.S. House of Representatives OLRC, Accessed Mar. 9, 2024.

4 U.S. Health Resources & Services Administration. Email Correspondence - EUA Vaccines and VICP. National Vaccine Information Center Aug. 24-30, 2021.

5 U.S. Health Resources & Services Administrations. Advisory Committee Nominations - ACCV. September 2023.

6 Grimes R. National Vaccine Injury Compensation Program (VICP) Update. U.S. Health Resources & Services Administration Mar. 7, 2024.

7 Grimes R. National Vaccine Injury Compensation Program (VICP) Update. U.S. Health Resources & Services Administration Mar. 7, 2024.

8 Data & Statistics – March 1, 2024. Health Resources & Services Administration.

9 Altarum Institute. Determining the Feasibility of Evaluating the National Vaccine Injury Compensation Program. Final Report. Jun. 15, 2009.

10 Grimes R. National Vaccine Injury Compensation Program (VICP) Update. U.S. Health Resources & Services Administration Mar. 7, 2024.

11 National Vaccine Injury Compensation Program Monthly Statistics Report - March 2024. U.S. Health Resources & Services Administration.

12 National Vaccine Injury Compensation Program Monthly Statistics Report - March 2024. U.S. Health Resources & Services Administration.

13 Vaccine Injury Compensation Trust Fund - Treasury Managed, Health and Human Services, Federal Account Symbol: 075-8175. USASpending.gov Accessed Mar. 10, 2024.

Leave a comment

Your email address will not be published. Required fields are marked with an *

Name is a required field
Please enter a valid email address
Please enter a comment.
6 Responses to "Impending Changes to Vaccine Injury Compensation "
Commenter Name
Posted: 4/25/2024 4:56:39 PM
Two of our neighbors died from the COVID vaccine. The first one was in his 40's and died of a cardiac arrest, he never felt good after getting a single vaccine. The second on died of liver cancer, he was in his 60's. They both left behind wives and the 40-year-old left behind 3 children. The 60-year-old left behind adult children. I heard that they are coming out with a new virus and vaccine target for children. Please do not vaccinate!
Commenter Name
Robert Walton
Posted: 4/25/2024 4:57:41 PM
Thank you. This is invaluable information. Sharing over social media!
Commenter Name
Janelle Fornecker
Posted: 4/25/2024 5:18:53 PM
With the impending litagation coming in the near future concerning this Covid gene shot and the push for this on kids and the findings in Australia on the bypassing of GMO laws I would say it looks like people are trying to get ahead of the fallout.
Commenter Name
Posted: 4/25/2024 7:51:39 PM
My husband died 2 days after getting the covid vaccine. I think he was too ill to get the vaccine and that it ended up killing him. I know that I won't ever see compensation for his death. Sure glad I said no to the vaccine.
Commenter Name
Posted: 4/28/2024 6:59:59 PM
I had the hospital back in 1999, give my 2 day old son a hep B vaccine without consent!!! You have to never leave your baby out of your sight, when in the hospital!
Commenter Name
Ronda Ferguson
Posted: 5/7/2024 1:21:51 AM
My dad got dementia from this shot and died. He was 77 very active . I told him not to take them shots but went down hill and had 3 shots. He was forced I think. He was in a retirement home. I wish I could Sue them for that.
Make A Difference

NVIC is 100% funded by donations.

Connect with Us!

Ask 8 Information Kiosk

Explore FREE downloadable educational materials

NVIC Websites:
Opens in new tab, window
Opens an external site
Opens an external site in new tab, window